Back to News
Market Impact: 0.35
CollPlant Biotechnologies To Acquire Israeli Deep-tech Company LightSolver
Source: Nasdaq
M&A & RestructuringTechnology & InnovationCompany Fundamentals
CollPlant Biotechnologies (CLGN) signed a definitive agreement to acquire Israeli deep-tech firm LightSolver, with the deal expected to close later in the week. The announcement signals expansion into new technology and is likely supportive for sentiment, though specific deal terms and financial impact were not provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
CLGN0.35
More News
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- Penske Automotive agrees to be taken private by Penske, Mitsui
- Faraday Copper completes acquisition of BHP’s San Manuel project
- Supermicro promised a new CFO in December 2024. A $2.5 billion smuggling case and a co-founder’s arrest later, it has one
- Blackstone President Jon Gray Bets Big on AI Boom
- Ukraine to resume strikes on Russian refineries, shattering hopes of an 'energy ceasefire'
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- 2026 Global Markets Outlook: Asset Allocation After the Great Disconnect
- Fintool Alternatives After the Microsoft Acquisition